Effector-Binding-Directed Dimerization and Dynamic Communication between Allosteric Sites of Ribonucleotide Reductase

Biochemistry. 2019 Feb 12;58(6):697-705. doi: 10.1021/acs.biochem.8b01131. Epub 2019 Jan 8.

Abstract

Proteins forming dimers or larger complexes can be strongly influenced by their effector-binding status. We investigated how the effector-binding event is coupled with interface formation via computer simulations, and we quantified the correlation of two types of contact interactions: between the effector and its binding pocket and between protein monomers. This was achieved by connecting the protein dynamics at the monomeric level with the oligomer interface information. We applied this method to ribonucleotide reductase (RNR), an essential enzyme for de novo DNA synthesis. RNR contains two important allosteric sites, the s-site (specificity site) and the a-site (activity site), which bind different effectors. We studied these different binding states with atomistic simulation and used their coarse-grained contact information to analyze the protein dynamics. The results reveal that the effector-protein dynamics at the s-site and dimer interface formation are positively coupled. We further quantify the resonance level between these two events, which can be applied to other similar systems. At the a-site, different effector-binding states (ATP vs dATP) drastically alter the protein dynamics and affect the activity of the enzyme. On the basis of these results, we propose a new mechanism of how the a-site regulates enzyme activation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allosteric Regulation / physiology
  • Allosteric Site
  • Catalytic Domain
  • Humans
  • Molecular Dynamics Simulation
  • Protein Multimerization / physiology
  • Ribonucleotide Reductases / chemistry
  • Ribonucleotide Reductases / metabolism*
  • Thymine Nucleotides / chemistry
  • Thymine Nucleotides / metabolism*

Substances

  • Thymine Nucleotides
  • Ribonucleotide Reductases
  • thymidine 5'-triphosphate